Skip to content

the Effect of Probiotics on Aging Population

Study for the Effect of Probiotics on Aging Population

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04911556
Acronym
TEOPOGP
Enrollment
120
Registered
2021-06-03
Start date
2021-06-01
Completion date
2022-12-31
Last updated
2021-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Debility

Keywords

intestinal flora

Brief summary

This study intends to recruit aging population (over 65 years old). The investigators use 16 SrDNA sequencing technology, genome sequencing technology, metabonomics, random forest forecast model, analysing and selecting specific age-related intestinal flora. The investigators select probiotics slowing down senility. Then the investigators use the probiotics to intervene in the aging population. Finally the investigators observe whether the probiotics can delay aging.

Detailed description

This project plans to recruit the aging population (aged over 65 years old) and comprehensively analyze the public database and self-sequencing clinical big data by using 16 srDNA sequencing technology, metagenomic sequencing technology, metabonomics methods and Random Forest (R) prediction model to judge the key bacterial communities and related functional pathways related to aging.Based on the analysis results, the probiotics with the potential to alleviate aging were selected for intervention evaluation of aging population. This topic aims to explore the change process of intestinal flora structure and composition related to aging process.Identify the key intestinal bacteria genera/species/strains associated with aging, and target the pathway and metabolic characteristic spectrum of the key bacterial communities associated with aging;And select and breed specific intestinal bacterial strains related to aging.The aim is to reduce the age-related metabolic abnormalities and chronic inflammation, reduce medical treatment, rationally allocate medical resources, reduce medical costs and improve the quality of life.

Interventions

DIETARY_SUPPLEMENTBifidobacterium longum

types of intestinal flora

DIETARY_SUPPLEMENTA placebo made of starch

placebo

Sponsors

Jiangnan University
CollaboratorOTHER
Wuxi People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Participant ,care provider,investigator and outcomes Assessor are all blind.

Intervention model description

One group served as a control group, while the other three groups are treated with different strains of bifidobacterium longum

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Over 65 years old 2. Frail scale score above 3 points

Exclusion criteria

1. Severe impairment of liver and kidney function 2. The tumor is advanced and life expectancy is less than 2 years 3. Severe cognitive impairment and inability to cooperate 4. Unable to give informed consent 5. Have participated in other study before

Design outcomes

Primary

MeasureTime frameDescription
Points of probiotics intervention in aging populationone yearThe score of Frail scale 0 points is defined as normal.And 1 to 3 points is defined as the early age of debility.Three points or more is defined as debility.The score is lower than before, meaning probiotic intervention can alleviate debility.

Contacts

Primary ContactKan Hong, doctor
2898456291@qq.com13358119885

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026